Reducing the harm of opioid overdose with the safe use of naloxone: a pharmacologic review
The DOI matches its Crossref record; 97 of the 98 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Opioid overdose fatality has increased threefold since 1999. As a result, prescription drug overdose surpassed motor vehicle collision as the leading cause of unintentional injury-related death in the USA. Naloxone , an opioid antagonist that has been available for decades, can safely reverse opioid overdose if used promptly and correctly. However, clinicians often overestimate the dose of naloxone needed to achieve the desired clinical outcome, precipitating acute opioid withdrawal syndrome (OWS). AREAS COVERED: This article provides a comprehensive review of naloxone's pharmacologic properties and its clinical application to promote the safe use of naloxone in acute management of opioid intoxication and to mitigate the risk of precipitated OWS. Available clinical data on opioid-receptor kinetics that influence the reversal of opioid agonism by naloxone are discussed. Additionally, the legal and social barriers to take home naloxone programs are addressed. EXPERT OPINION: Naloxone is an intrinsically safe drug, and may be administered in large doses with minimal clinical effect in non-opioid-dependent patients. However, when administered to opioid-dependent patients, naloxone can result in acute opioid withdrawal. Therefore, it is prudent to use low-dose naloxone (0.04 mg) with appropriate titration to reverse ventilatory depression in this population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Naloxone reversal depends on several factors: the dose of naloxone administered and its elimination half-life, the k off value of the opioid that requires reversal, and the potency of naloxone in dissociating the opioid from the mu-opioid receptor, which depends on the K D (dissociation constant) [49,50].”
From Nitazenes: review of comparative pharmacology and antagonist action (2025) · cites this paper as [49]
Citations
Cites
Harrison's Principles of Internal Medicine.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-499_2 · Cited by 12,514
Harrison’s Principles of Internal Medicine
Malani, P. N. (2012) · JAMA · doi:10.1001/jama.308.17.1813-b · Cited by 2,039
Deaths: preliminary data for 2003.
Hoyert, D. L., Kung, H.-C., & Smith, B. L. (2005) · PubMed · Cited by 1,649
Rosen's emergency medicine : concepts and clinical practice.
Marx, J. A. (2017) · Cited by 1,258
Rosenʼs emergency medicine: concepts and clinical practice
Rotheray, K. R., & Cattermole, G. N. (2010) · European Journal of Emergency Medicine · doi:10.1097/mej.0b013e32833728f4 · Cited by 1,120
Emergency Medicine: A Comprehensive Study Guide
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-8-703_2 · Cited by 1,111
Medication-Assisted Therapies — Tackling the Opioid-Overdose Epidemic
Volkow, N. D., Frieden, T. R., Hyde, P. S., & Cha, S. S. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1402780 · Cited by 1,015
A Flood of Opioids, a Rising Tide of Deaths
Okie, S. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1011512 · Cited by 830
Incidence, reversal, and prevention of opioid-induced respiratory depression
Dahan, A., Aarts, L., & Smith, T. W. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181c38c25 · Cited by 634 · cited 1×
“Naloxone, an N-allyl derivative of oxymorphone and thebaine (a pharmaceutical precursor for certain opioids), was synthesized in 1960 as the first pure competitive opioid receptor antagonist and introduced into clinical use in 1967 (Figure 1) [11,12].”
BackgroundManagement of Opioid Analgesic Overdose
Boyer, E. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1202561 · Cited by 605
Research works printed but not linked: 15
- Paulozzi LJ, 2011, MMWR Surveill Summ, 60, 60
- Kochanek KD, 2011, Natl Vit Stat Rep, 59, 51
- Centers for Disease C, Prevention, 2012, MMWR. Morb Mortal Wkly Rep, 61, 493
- Nelson LS, 2015, Opioid Antagonists
- Kim S, 1997, J Nucl Med, 38, 1726
- 10.1097/00000542-200607000-00012 · DOI · Paper page
- Anderson JA, 1988, Anesth Prog, 35, 43
- Longnecker DE, 2012, Anesthesiology
- Stone CK, 2008, Current diagnosis & treatment emergency medicine
- Connors NC, 2014, J Med Tox, 10, 76
- Atchabahian A, 2013, The anesthesia guide
- 10.1001/jama.1995.03530070060031 · doi:10.1001/jama.1995.03530070060031
- Lewis JM, 1984, Am J Dis Child, 138, 944
- Straus MM, 2013, Subst Abuse Rehabil, 2013
- Centers for Disease Control and Prevention, 2012, MMWR Morb Mortal Wkly Rep, 61, 101
Cited by
Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review
Armenian, P., Vo, K. T., Barr-Walker, J., & Lynch, K. L. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.10.016 · Cited by 710
“In addition to the route of administration, naloxone effectiveness and duration of action depends on the type and dose of the opioid involved, and typically does not remain effective past 90 min (Kim and Nelson, 2015).”
BackgroundInfluentialMisuse of Novel Synthetic Opioids: A Deadly New Trend
Prekupec, M. P., Mansky, P. A., & Baumann, M. H. (2017) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000324 · Cited by 283
“The recommended initial dose of naloxone is 0.4 to 2 mg (Zimmerman, 2014; Kim and Nelson, 2015).”
BackgroundInfluentialDesigner drugs: mechanism of action and adverse effects
Luethi, D., & Liechti, M. E. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02693-7 · Cited by 262
The Opioid Epidemic in the United States
Wilkerson, R. G., Kim, H. K., Windsor, T. A., & Mareiniss, D. P. (2016) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2015.11.002 · Cited by 160
Self-citationHigher doses of naloxone are needed in the synthetic opioid era
Moss, R. B., & Carlo, D. J. (2019) · Substance Abuse Treatment, Prevention, and Policy · doi:10.1186/s13011-019-0195-4 · Cited by 155
“The clinical effects observed in OWS due to excessive or overly rapid reversal of opioid overdose includes vomiting, seizure, delirium, and agitation [18].”
Background
Metadata
- Authors
- Kim, H. K., & Nelson, L. S.
- Affiliations
- University of Maryland, Baltimore (US)
- Bellevue Hospital Center (US)
- Venue
- Expert Opinion on Drug Safety
- Publisher
- Informa UK Limited
- Published
- 2015-04-12
- Volume
- 14
- Issue
- 7
- Pages
- 1137-1146
- ISSN
- 1474-0338 (ISSN-L)
- 1744-764X
- OpenAlex
- W2126273530
- Cited by
- 116
- References
- 98
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 8 · 2023: 6 · 2022: 16 · 2021: 8 · 2020: 16 · 2019: 18 · 2018: 7 · 2017: 11 · 2016: 6 · 2015: 2
- FWCI
- 1.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Opinion on Drug Safety (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- naloxone, opioid overdose, opioid antagonists, opioid toxicity, opioid overdose deaths, opioid use disorder
- MeSH terms
- Analgesics, Opioid, Humans, Naloxone, Narcotic Antagonists, Treatment Outcome, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reducing the harm of opioid overdose with the safe use of naloxone: a pharmacologic review. https://app.cochat.ai/papers/10.1517/14740338.2015.1037274
- The paper
- Kim, H. K., & Nelson, L. S. (2015). Reducing the harm of opioid overdose with the safe use of naloxone: a pharmacologic review. Expert Opinion on Drug Safety. https://doi.org/10.1517/14740338.2015.1037274
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.